✦ LIBER ✦

137 Optimising anti-HER2 therapy in early breast cancer

✍ Scribed by M. Piccart; P. Bedard; E. de Azambuja

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-HER2 neoadjuvant and adjuvant thera

✍ V. Guarneri; E. Barbieri; M.V. Dieci; F. Piacentini; P. Conte 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Breast cancer: Increasing therapy option

✍ Harbeck, Nadia 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 29 KB

Is there a case for anti-HER2 therapy wi

✍ Anastasia Constantinidou; Ian Smith 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Anti-HER2 vaccines: new prospects for br

✍ Maha Zohra Ladjemi; William Jacot; Thierry Chardès; André Pèlegrin; Isabelle Nav 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 283 KB

349 Targeted therapy – novel anti-HER2 s

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Impact of anti-HER2 therapy on overall s

✍ Bartsch, R; Berghoff, A; Pluschnig, U; Bago-Horvath, Z; Dubsky, P; Rottenfusser, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 329 KB